Get started
Author

María del Carmen Vennera

Observed names: M Vennera, M. Vennera, M. d. C. Vennera, M. del Carmen Vennera, Maria del Carmen Vennera, María Del Carmen Vennera, María del carmen Vennera, Mª Carmen Vennera, Mª del Carmen Vennera
OpenAlex ID: A5111879770
Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry
2013 · Luis Pérez de Llano, María del Carmen Vennera, et al. · Journal of Asthma · 107
Efficacy of omalizumab in the treatment of nasal polyps
2010 · M. d. C. Vennera, C. Picado, et al. · Thorax · 98
PDF
Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry—Some New Approaches
2012 · María Del Carmen Vennera, Luis Pérez De Llano, et al. · Journal of Asthma · 97
Duration of the efficacy of omalizumab after treatment discontinuation in ‘real life’ severe asthma
2017 · Maria del Carmen Vennera, Carlos Sabadell, et al. · Thorax · 75
PDF
Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain.
2011 · S Quirce, V Plaza, et al. · PubMed · 65
Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain
2016 · María del Carmen Vennera, Antonio Valero, et al. · Clinical Drug Investigation · 33
Severity and outcomes of community acquired pneumonia in asthmatic patients
2014 · Silvia Terraneo, Eva Polverino, et al. · Respiratory Medicine · 21
PDF
Is asthma in the elderly different? Functional and clinical characteristics of asthma in individuals aged 65 years and older
2019 · Elena Curto, Astrid Crespo-Lessmann, et al. · Asthma Research and Practice · 20
PDF
Psychological Profile of Patients with Bronchial Asthma and Functional Dyspnea: A Comparison with a Non-Asthmatic Population and Impact on the Disease
2011 · Carlos Martínez-Rivera, M. del Carmen Vennera, et al. · Archivos de Bronconeumología · 19
A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy
2018 · Luis Pérez de Llano, Juan Luis García-Rivero, et al. · The Journal of Allergy and Clinical Immunology In Practice · 17
Perfil psicológico de los pacientes con asma bronquial y disnea funcional: comparación con población no asmática e impacto sobre la enfermedad
2011 · Carlos Martínez-Rivera, M. del Carmen Vennera, et al. · Archivos de Bronconeumología · 16
Factors Associated With Severe Uncontrolled Asthma and the Perception of Control by Physicians and Patients
2014 · María del Carmen Vennera, César Picado, et al. · Archivos de Bronconeumología · 14
Factores asociados con el asma grave no controlada y con la percepción del control por parte de médicos y pacientes
2014 · María del Carmen Vennera, César Picado, et al. · Archivos de Bronconeumología · 13
Novel diagnostic approaches and biological therapeutics for intrinsic asthma
2014 · María del Carmen Vennera, Cesar Picado · International Journal of General Medicine · 6
PDF
Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
2015 · Ina Sintobin, Maria del Carmen Vennera, et al. · Clinical and Translational Allergy · 2
PDF
Patologías mediadas por la inmunoglobulina E: de la inmunoglobulina E al omalizumab
2012 · María del Carmen Vennera, César Picado · Inmunología · 1
Psychological Profile Of Asthmatic Patients With Dysfunctional Breathing And Its Impact On Asthma Outcome
2010 · Carlos Martinez, Concepcion Cañete, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Dysfunctional Breathing Associated With Asthma. Psychological Profile Differences Between Asthmatics And Non Asthmatic People
2010 · Concepcion Cañete, Carlos Martinez, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Acetónido de triamcinolona en el tratamiento del asma resistente a los glucocorticoides: riesgos y beneficios
2008 · César Picado, María del Carmen Vennera · Archivos de Bronconeumología · 1
The creation and long-term follow-up of a cohort of asthmatic patients. Baseline clinical characteristics of the study population: The MEGA Project:
2017 · Xavier Munoz, Ebymar Arismendi, et al. · European Respiratory Journal
A simple score for future risk prediction in patients with controlled asthma who undergo a step-down guidelines-based strategy
2017 · Luis Pérez De Llano, Francisco Carballada, et al. · European Respiratory Journal
Total and free IgE in evolution of severe asthma after omalizumab treatment
2016 · María del Carmen Vennera, Mariona Pascal, et al. · European Respiratory Journal
PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control Study
2011 · J. Galera, R. Lahoz, et al. · Value in Health
PDF
PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma: Patients and Caregivers in the Spanish Pediatric Population: A Prex Study
2011 · J. Galera, R. Lahoz, et al. · Value in Health
Omalizumab (Xolair®) in Severe Uncontrolled Asthma: Two-Year Clinical Experience.
2009 · M Vennera, A Valero, et al. · American Journal of Respiratory and Critical Care Medicine
Works count: 26
Citation count: 607
H-index: 13
I10-index: 13
Year
Topic
Type